Literature DB >> 758719

[Retinoid-selective ultraviolet phototherapy (SUP) in psoriasis].

G K Steigleder, C E Orfanos, H Pullmann.   

Abstract

27 patients with generalized psoriasis were treated with oral administration of Ro 10-9359 (50--75 mg/d) and daily radiations with a source emitting UVA and UVB light at 292.5--335 nm (so called selective UV-phototherapy, SUP). In 24 patients full remission was seen, partly with few remaining lesions at the predilection sites. The average number of sessions necessary for clearing was 21.6 in 5.3 weeks. The total energy required was 68 J/cm2. Only slight side effects, such as cheilitis and hair loss (4 cases) were seen. The clinical efficacy of this combined retinoid-UV-treatment is comparable to the therapeutic effect of systemic PUVA; however, its practicability seems to be higher, and its application on an out-patient basis better.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 758719

Source DB:  PubMed          Journal:  Z Hautkr        ISSN: 0301-0481


  4 in total

Review 1.  The retinoids. A review of their clinical pharmacology and therapeutic use.

Authors:  C E Orfanos; R Ehlert; H Gollnick
Journal:  Drugs       Date:  1987-10       Impact factor: 9.546

2.  [Reversible impairment of spermatogenesis induced by aromatic retinoid in guinea pigs (author's transl)].

Authors:  D Tsambaos; M Hundeiker; G Mahrle; C E Orfanos
Journal:  Arch Dermatol Res       Date:  1980       Impact factor: 3.017

3.  Effects of selective ultraviolet phototherapy (SUP) and local PUVA treatment on DNA synthesis in guinea pig skin.

Authors:  H Pullmann; A Galosi; C Jakobeit; G K Steigleder
Journal:  Arch Dermatol Res       Date:  1980       Impact factor: 3.017

Review 4.  Etretinate. A review of its pharmacological properties and therapeutic efficacy in psoriasis and other skin disorders.

Authors:  A Ward; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-07       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.